APA (7th ed.) Citation

K, M., K, T., T, F., & H, M. (2025). SGLT-2 Inhibitors Are Potent to Suppress Aggressive Transformation From Indolent Type of Adult T-Cell Leukemia/Lymphoma: Unique Insight Into Therapeutics for Diabetes-Related Hematological Malignancy. EJHaem, 6(5), e70109. https://doi.org/10.1002/jha2.70109

Chicago Style (17th ed.) Citation

K, Morichika, Tamaki K, Fukushima T, and Masuzaki H. "SGLT-2 Inhibitors Are Potent to Suppress Aggressive Transformation From Indolent Type of Adult T-Cell Leukemia/Lymphoma: Unique Insight Into Therapeutics for Diabetes-Related Hematological Malignancy." EJHaem 6, no. 5 (2025): e70109. https://doi.org/10.1002/jha2.70109.

MLA (9th ed.) Citation

K, Morichika, et al. "SGLT-2 Inhibitors Are Potent to Suppress Aggressive Transformation From Indolent Type of Adult T-Cell Leukemia/Lymphoma: Unique Insight Into Therapeutics for Diabetes-Related Hematological Malignancy." EJHaem, vol. 6, no. 5, 2025, p. e70109, https://doi.org/10.1002/jha2.70109.